Stephanie Lynn Ciarlone

Title: Innovations in Treating Angelman Syndrome by Stephanie Lynn Ciarlone

Introduction

Stephanie Lynn Ciarlone is an accomplished inventor based in Bassett, VA (US). She has made significant contributions to the field of medical research, particularly in the treatment of Angelman Syndrome. With a total of 2 patents, her work focuses on innovative methods to improve the quality of life for individuals affected by this condition.

Latest Patents

Ciarlone's latest patents include groundbreaking inventions related to ketone supplements for the treatment of Angelman Syndrome. The first patent describes a method of treating Angelman Syndrome by inducing ketosis in a subject through the administration of a therapeutically effective amount of a ketone ester, such as an R,S-1,3-butanediol acetoacetate ester. This method aims to elevate the blood ketone level in the subject, which can lead to increased cognitive and motor function, as well as a reduction in seizures. The second patent reiterates similar methods and outcomes, emphasizing the potential benefits of ketone esters in managing Angelman Syndrome.

Career Highlights

Ciarlone is affiliated with the University of South Florida, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to treating neurological disorders, particularly those that affect cognitive and motor functions.

Collaborations

She collaborates with notable colleagues, including Edwin John Weeber and Dominic Paul D'Agostino, who share her commitment to advancing research in this vital area of healthcare.

Conclusion

Stephanie Lynn Ciarlone's contributions to the treatment of Angelman Syndrome through her innovative patents highlight her dedication to improving the lives of those affected by this condition. Her work exemplifies the impact of research and innovation in the medical field.